Summary of Flutter Entertainment Conference Call Company Overview - **Company**: Flutter Entertainment (NYSE: FLUT) - **Date**: March 04, 2026 - **Key Financials**: Revenue increased by 17%, EBITDA increased by 21% [3][3] U.S. Market Performance - **iGaming Business**: Achieved 28% of Gross Gaming Revenue (GGR) in Q4 2025, indicating strong performance and effective strategy in exclusive content and loyalty programs [5][5] - **Sports Business**: Remains the number one operator in the U.S. despite losing some market share in 2025. The company is aware of the issues and has plans to address them [7][7] - **Handle and Margin**: Noted a deceleration in handle, which is expected due to increased margins. The company achieved a 19% margin on football, significantly higher than previous years [11][11][13][13] - **Generosity Strategy**: The execution of the generosity strategy was less effective in Q4, impacting customer retention and handle. The company plans to improve this with a new loyalty program [25][25][51][51] Guidance and Future Outlook - **2026 Guidance**: The guidance reflects some conservatism regarding handle growth, with expectations for a gradual improvement throughout the year. The iGaming segment is expected to see high teens revenue growth year-on-year [30][30][31][31] - **Product Initiatives**: Plans to launch a loyalty program for sports, which has been successful in the casino segment, and to enhance product offerings [28][28][33][33] Competitive Landscape - **Market Position**: Flutter maintains a strong position in parlays and is focused on improving user experience and app performance [33][33][34][34] - **World Cup Opportunity**: The upcoming World Cup is seen as a significant opportunity for customer acquisition, especially in markets like Brazil [46][46][50][50] International Markets - **Italy**: Strong performance in Italy post-acquisition of Sisal, with expectations for continued growth. The online licensing event is not expected to significantly change market share [88][88][89][89] - **Brazil**: Increased investment in Brazil is anticipated to yield strong growth, particularly with the upcoming World Cup [92][92][95][95] Financial Strategy - **Cash Conversion**: Adjusted free cash flow conversion is expected to improve from 25% in 2025 to the low to mid-thirties in 2026, with a long-term target of over 40% [105][105] - **Cost Management**: The company is focused on cost efficiencies and transformation initiatives to enhance profitability [102][102] Key Risks and Considerations - **Tax Changes in the UK**: The company is preparing for tax changes that may impact profitability but remains optimistic about growth opportunities in the UK market [97][97][98][98] - **Regulatory Environment**: The evolving regulatory landscape in the U.S. presents both challenges and opportunities for expansion, particularly in states where online sports betting is not yet regulated [71][71][78][78] Conclusion - Flutter Entertainment is positioned for growth in both the U.S. and international markets, with a focus on enhancing customer experience through loyalty programs and product improvements. The company is optimistic about its future prospects, particularly with upcoming events like the World Cup and ongoing transformation initiatives.

Summary of Telix Pharmaceuticals Update - March 04, 2026 Company and Industry Overview - **Company**: Telix Pharmaceuticals (NasdaqGS:TLX) - **Industry**: Prostate Cancer Imaging and Theranostics Key Points and Arguments Current Clinical Landscape - The discussion focused on innovations in PSMA PET/CT imaging for prostate cancer, highlighting its critical role in diagnosis and treatment planning [3][4] - PSMA PET imaging has gained strong clinical support in urology for diagnosing and staging prostate cancer, outperforming traditional MRI in sensitivity and patient acceptance [4][5][8] Advances in Imaging Technology - Significant advances in PSMA PET imaging have been made over the last five years, with expectations for further innovations in the next 5 to 10 years [3] - The introduction of advanced PET/CT cameras, such as the Siemens Quadra, has improved sensitivity for detecting small volumes of disease, enhancing diagnostic accuracy [13][14] Clinical Applications of PSMA PET Imaging - PSMA PET imaging is utilized at various stages: diagnosis, staging, biochemical recurrence, therapeutic pathway determination, and monitoring treatment response [6][8] - A recent phase 3 study in a Chinese population demonstrated high positive predictive value for gallium PSMA PET across different PSA levels, indicating its effectiveness in clinical practice [9][10] Supply Chain and Production Flexibility - The gallium isotope supply chain has matured, with multiple generator manufacturers ensuring consistent access and delivery, which is crucial for patient access [45][46] - New technologies, such as ARTMS, are expected to enhance gallium production capacity, further supporting the growing demand for PSMA PET imaging [48][50] Future of Imaging Tracers - The potential introduction of new isotopes, such as copper-based tracers, is being explored, but existing gallium-based imaging remains the primary focus due to its established clinical utility [51][62] - The need for novel targets in imaging is emphasized, as current PSMA-targeted imaging has limitations in certain patient populations [62][64] Business Model and Economic Impact - The integration of PSMA PET imaging into clinical practice has significant operational and economic implications for high-volume urology practices, enhancing patient management and treatment planning [28][30] - The efficiency of imaging operations is critical, with a focus on optimizing throughput and minimizing logistical challenges in patient scheduling and scanning [33][34] Research and Clinical Trials - Participation in clinical trials, such as the BYPASS study, aims to explore the utility of PSMA PET in pre-diagnostic screening and active surveillance, potentially reducing unnecessary biopsies [36][39] - The impact of molecular imaging on clinical decision-making and patient outcomes is a key area of interest for ongoing research [30][41] Additional Important Content - The discussion highlighted the challenges of interpreting imaging results and the importance of advanced imaging techniques in accurately diagnosing and managing prostate cancer [70][74] - The role of PSMA PET imaging in guiding surgical decisions and improving patient outcomes was emphasized, particularly in reducing surprises during surgery [74] This summary encapsulates the critical insights from the Telix Pharmaceuticals update, focusing on the advancements in prostate cancer imaging, the evolving supply chain, and the implications for clinical practice and research.

Veeva Systems (NYSE:VEEV) Q4 2026 Earnings call March 04, 2026 05:00 PM ET Company ParticipantsAdam Hotchkiss - Vice President, Emerging Software Equity ResearchAlexei Gogolev - Executive Director, North America Equity ResearchBrian Van Wagener - CFODavid Hynes Jr. - Managing DirectorGunnar Hansen - Director of Investor RelationsMatt Shea - AssociatePaul Shawah - EVP, StrategyPeter Gassner - CEOTyler Radke - Co Head US Software Equity ResearchConference Call ParticipantsAndrew DeGasperi - AnalystBrian Peter ...

Financial Data and Key Metrics Changes - Ooma reported Q4 revenue of $74.6 million, a 15% increase year-over-year, driven by growth in Ooma Business and the acquisitions of FluentStream and Phone.com [19] - Adjusted EBITDA for Q4 reached $11.5 million, representing 15% of revenue, compared to 11% of revenue a year ago [6][27] - Non-GAAP net income for Q4 was $9.4 million, a 62% increase year-over-year [21] - Total revenue for fiscal 2026 was $273.6 million, up 7% from $256.9 million in the prior year [20] Business Line Data and Key Metrics Changes - Business subscription and services revenue grew 23% year-over-year in Q4, driven by user growth and ARPU increases [21] - Residential subscription and services revenue decreased by 1% year-over-year in Q4 [21] - The number of core users at the end of Q4 was 1.4 million, including 164,000 business core users from acquisitions, up from 1.2 million at the end of Q3 [24] Market Data and Key Metrics Changes - Ooma's annual exit recurring revenue was $291 million, up 24% year-over-year [24] - The company ended Q4 with a net dollar retention rate of 99% [23] - The number of AirDial lines installed in Q4 more than doubled compared to the same quarter last year, with new bookings growing approximately 80% year-over-year [20][27] Company Strategy and Development Direction - Ooma plans to introduce AI solutions on its Ooma Office platform, including transcription and summarization of calls, and an AI-powered answering service [9] - The company aims to expand its AirDial business, capitalizing on rising POTS prices and increasing shutdowns of POTS lines [10] - Ooma intends to pay down debt from recent acquisitions and pursue further acquisitions to enhance growth [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's position for fiscal 2027, citing strong execution and positive market trends, particularly for AirDial [33] - The company anticipates Adjusted EBITDA for fiscal 2027 to exceed $40 million, with a focus on acquisitions and stock repurchases [7] - Management noted that the residential business is expected to remain stable, with potential growth from the upcoming MyPhone product [15] Other Important Information - Ooma completed the acquisition of FluentStream for approximately $45 million and Phone.com for about $23.2 million, funded by a $65 million term loan [18] - The company generated $10.7 million of operating cash flow in Q4 and $22 million of free cash flow for the full year [28] Q&A Session Summary Question: Does the fiscal year 2027 guidance include potential cost synergies from Phone.com? - Management stated that the guidance does not assume synergy benefits yet, aiming to start conservatively [36] Question: What is the expectation for the pace of AirDial deployments this year? - Management expects a significant increase in deployments due to strong market interest and pricing trends [38] Question: Will the company likely close additional acquisitions this year? - Management expressed hope for further acquisitions, viewing them as a key growth avenue [39] Question: How is the AirDial installation goal progressing? - Management reported strong performance in AirDial installations, exceeding goals for hospitality customers [44] Question: What is the market opportunity for the MyPhone product? - Management believes there is a significant market opportunity for MyPhone, targeting families with children [46] Question: What is the ARPU outlook with the new acquisitions? - Management indicated that the ARPU for FluentStream and Phone.com is slightly lower than Ooma Office but comparable [72] Question: What criteria does the company follow for acquisitions? - Management noted that they evaluate acquisitions based on EBITDA and potential synergies, aiming for accretive deals [78]

Financial Data and Key Metrics Changes - The company generated net investment income of $42.3 million, or $1.05 per share, on total investment and other income of $90.9 million for the full year [28] - The weighted average annualized portfolio yield on debt investments was 13.7% for the year, down from 15.7% in the prior year, reflecting a lower interest rate environment [28] - Net asset value (NAV) increased year-over-year to $8.73 per share at December 31, 2025, compared to $8.61 per share at December 31, 2024 [31] Business Line Data and Key Metrics Changes - The investment portfolio grew by over $100 million, or 15%, as a result of new fundings exceeding prepayment, repayment, and amortization within the portfolio [19] - The company closed $508 million of new debt commitments to venture growth stage companies, a significant increase from $175 million in 2024 [5] - Fundings for the year reached $287 million, more than double the previous year's $135 million [17] Market Data and Key Metrics Changes - Venture capital deal value increased to $339 billion across more than 16,000 deals as of the end of 2025, marking the second highest in a decade [7] - Deal value in the core venture growth market segment rose 131% year-over-year [7] - The company ended the year with a pipeline exceeding $2 billion, benefiting from increased venture capital investment activity [6] Company Strategy and Development Direction - The company aims to create enduring shareholder value by increasing scale, durability, income-generating assets, and NAV [4] - There is a focus on portfolio diversification, geographic and investment sector rotation, particularly in high-potential sectors leveraging AI [8] - The company is positioning itself to benefit from trends in aerospace, defense, infrastructure, and advanced manufacturing, aligning with national priorities [12] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the venture market's health and signs of liquidity with M&A and IPOs, indicating a well-positioned stance for realizing shareholder value [12] - The company is cautious about macroeconomic impacts but is actively resolving credit situations and making progress [51] - Management believes that the combination of durable AI tailwinds, strong demand, and disciplined underwriting will position the company well for growth in 2026 and beyond [15] Other Important Information - The advisor's income incentive fee waiver has been extended through 2026, and the sponsor purchased more than 1.8 million shares of the company during the third and fourth quarters [15] - The company ended the year with total liquidity of $252.4 million, consisting of cash equivalents and available capacity under the revolving credit facility [34] Q&A Session Summary Question: Is the number of companies raising money this quarter low in historical context? - Management indicated that the low number reflects the freshness of the portfolio vintages and expects fundraising activity to increase in 2026 and 2027 [43] Question: Is there a change in the long-term strategy given the current market conditions? - Management stated that the strategy is refined each year based on market conditions, focusing on strengthening the balance sheet and improving income-earning assets [44][46] Question: Have most negative marks been worked through in the portfolio? - Management expressed that while credit has stabilized, they are still proactive in resolving known situations and making progress [51] Question: What is the visibility on prepayments for the remainder of the quarter? - Management noted that there is currently not much visibility on prepayments for the remainder of the quarter but is monitoring the situation [53] Question: What are the expectations for M&A and IPO activity in 2026? - Management indicated that while IPO optimism may be delayed, M&A activity is picking up, and they remain cautiously optimistic about unique opportunities [62]

Cracker Barrel Old Country Store (NasdaqGS:CBRL) Q2 2026 Earnings call March 04, 2026 05:00 PM ET Company ParticipantsAdam Hanan - Director of Investor RelationsCraig Pommells - SVP and CFODennis Geiger - Executive Director of Equity ResearchJulie Masino - President and CEOConference Call ParticipantsJake Bartlett - Senior Equity Research AnalystJon Tower - Equity Research AnalystSara Senatore - Managing Director and Senior Equity Research AnalystTodd Brooks - Managing Director and Senior AnalystOperatorGoo ...

Ooma (NYSE:OOMA) Q4 2026 Earnings call March 04, 2026 05:00 PM ET Company ParticipantsArjun Bhatia - Partner and Co-Group Head of Technology, Media, and CommunicationsEric Stang - Chairman and CEOKincaid LaCorte - Equity Research AssociateMatt Robinson - Director of Investor Relations and Corporate DevelopmentShig Hamamatsu - CFOConference Call ParticipantsJosh Nichols - Senior Research AnalystMatthew Harrigan - Managing Director and Senior Equity Research AnalystMaxwell Michaelis - Research AnalystOperator ...

Everspin Technologies (NasdaqGM:MRAM) Q4 2025 Earnings call March 04, 2026 05:00 PM ET Company ParticipantsBill Cooper - CFOMonica Gould - Head of Investor RelationsSanjeev Aggarwal - President and CEOConference Call ParticipantsNeil Young - Equity Research AnalystRichard Shannon - Senior Research AnalystOperatorGood afternoon, welcome to Everspin Technologies' fourth quarter 2025 financial results conference call. At this time, all participants are in a listen-only mode. After the conclusion of management' ...

Financial Data and Key Metrics Changes - Earnings for Q4 2025 were $21 million, a $63 million improvement compared to Q4 2024. For the full year 2025, earnings were $12 million, a $72 million improvement [7][15] - Adjusted EBITDA for Q4 2025 was $28 million, a $36 million positive swing from last year. For 2025, adjusted EBITDA grew to $45 million, a $53 million improvement compared to 2024 [7][16] - Net sales for Q4 2025 were $232 million, $4 million lower than the prior year, reflecting a reduction in volume sold of 10.6 million gallons [10] Business Line Data and Key Metrics Changes - The Western production segment benefited from the Carbonic acquisition, contributing $1.4 million during Q4 2025 [12] - The average sales price per gallon increased to $2.10 from $1.88 per gallon, partially offsetting the reduction in volume sold [10] - Gross profit for Q4 2025 was $15.2 million, a significant increase of $16.6 million compared to Q4 2024's gross loss of $1.4 million [11] Market Data and Key Metrics Changes - The company expects to qualify approximately 90 million gallons of combined production on an annual basis for 45Z credits at its Columbia and Pekin dry mill facilities [8] - Renewable fuel export sales at premiums to domestic sales contributed $5 million on a higher volume and higher average sales price per gallon [11] Company Strategy and Development Direction - The company aims to focus on opportunities within its control to maximize earnings, including adjusting staffing and investing in plant efficiency [5][6] - Plans for 2026 include elevating capital expenditures to roughly $25 million while maintaining strong cost discipline and prioritizing high ROI projects [17][18] - The company is exploring large-scale CO2 utilization and sequestration opportunities at its Pekin campus [21] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in entering 2026 with a leaner cost structure and a higher mix of premium exports and carbon advantage volumes [19] - The first quarter is expected to be seasonally challenging due to extreme cold weather disrupting logistics and production [20] - Management believes the trajectory for E15 remains positive, supporting incremental ethanol demand over time [22] Other Important Information - The company recorded $7.5 million in 45Z credit earnings for the full year, contributing directly to the bottom line in Q4 2025 [14] - The company ended the year with a cash balance of $23 million and generated $10 million in cash flow from operations during Q4 2025 [16][17] Q&A Session Summary Question: What steps are being taken to increase 45Z tax credits? - Management is focused on lowering carbon intensity scores and increasing production capacity at the Pekin dry mill to capitalize on 45Z tax credits [26][27] Question: Are there expectations for revenue pickup in the Western asset in 2026? - Management intends to increase production capacity and overall utilization in the Western segment [30] Question: Can you quantify the ethanol exports locked in for the first half of 2026? - Management did not provide specific details but emphasized optimizing the value of products for export markets [39][40] Question: How has the company raised the floor for business performance? - Management highlighted improvements in operational efficiency, cost management, and diversification of revenue sources as key factors [46][48]

Cross Country Healthcare (NasdaqGS:CCRN) Q4 2025 Earnings call March 04, 2026 05:00 PM ET Company ParticipantsAmiee Hawkins - Chief Solutions and Operations OfficerBill Burns - CFOJosh Vogel - VP of Investor RelationsKevin Clark - CEOMarc Krug - Group President of DeliveryTobey Sommer - Managing DirectorConference Call ParticipantsBill Sutherland - Equity Research AnalystConstantine Davides - Managing Director and Senior Equity AnalystKevin Steinke - Sell-Side Equity Research AnalystTrevor Romeo - Equity Re ...